Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 10:20 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–168 of 176 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Gastrointestinal Polyps Clear all

Conditions: Polyp of Colon, Fistula
Interventions: X-Tack, Overstitch; Device
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Adenomatous Polyposis Coli
Interventions: Celecoxib, Placebo; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 10 Years to 17 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 23
States / cities: Chicago, Illinois • Ann Arbor, Michigan • Omaha, Nebraska + 16 more

Conditions: Nasal Polyps, Gastroesophageal Reflux
Interventions: lansoprazole; Drug
Lead sponsor: Head and Neck Surgery Associates; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Colonic Polyp, Colon Cancer
Interventions: Orton Score, Typical Standard of Care; Other
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 100 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Colo-rectal Cancer, Cancer Colon, Cancer, Rectum, Neoplasms,Colorectal, Polyps, Polyp of Colon, Adenoma, Adenoma Colon
Interventions: Not listed
Lead sponsor: Freenome Holdings Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 3,275 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 29
States / cities: Huntsville, Alabama • Chandler, Arizona • Tucson, Arizona + 25 more

Conditions: Ileal Pouch-Anal Anastomosis
Interventions: Not listed
Lead sponsor: Boston Medical Center; Other
Eligibility: Not listed
Enrollment: 936 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Colorectal Polyps
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Colon Cancer, Rectal Cancer
Interventions: celecoxib, placebo; Drug · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 30 Years and older
Enrollment: 1,170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2000
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: FAP, Familial Adenomatous Polyposis
Interventions: R-1,3-Butanediol (10G-A), R-1,3-Butanediol (20G-A), R-1,3-Butanediol (30G-A), R-1,3-Butanediol (30G-B); Dietary Supplement
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Colon Polyps, Colorectal Cancer, Inflammatory Bowel Disease (IBD)
Interventions: Colon KCC Heptapeptide; Biological
Lead sponsor: Danielle Kim Turgeon; Other
Eligibility: 18 Years to 100 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Colonic Polyps, Esophageal Diseases
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 225 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Colorectal Cancer, Adenomas Colon, Colon Cancer, Rectal Cancer, Colon Neoplasm, Colon Lesion, Colon Disease, Colon Polyp, Polyps, Adenoma, Rectal Diseases, Rectal Polyp, Gastrointestinal Neoplasms, Intestinal Neoplasms, Colonic Diseases, Functional, Intestinal Disease
Interventions: Next-Gen CRC Screening Test; Diagnostic Test
Lead sponsor: New Day Diagnostics; Network
Eligibility: 45 Years and older
Enrollment: 196 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 3
States / cities: Chula Vista, California • San Diego, California

Conditions: Colorectal Cancer, Precancerous Condition
Interventions: celecoxib, placebo; Drug · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 10 Years to 14 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2006
U.S. locations: 4
States / cities: Cleveland, Ohio • Houston, Texas

Conditions: Adenomatous Polyposis Coli
Interventions: Erlotinib, Sulindac, Placebo A, Placebo B; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 69 Years
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Familial Adenomatous Polyposis
Interventions: Curcumin, Laboratory Biomarker Analysis, Placebo; Drug · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 85 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Colorectal Cancer
Interventions: CB-17-08 CADe; Device
Lead sponsor: Cosmo Artificial Intelligence-AI Ltd; Industry
Eligibility: 45 Years and older
Enrollment: 249 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 7
States / cities: Scottsdale, Arizona • Danville, California • Jacksonville, Florida + 4 more

Conditions: Colorectal Adenoma, Colorectal Polyp, Colon Cancer
Interventions: EndoRings device; Device
Lead sponsor: Indiana University; Other
Eligibility: Not listed
Enrollment: 592 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Colorectal Cancer, Adenomatous Colorectal Polyps, Precancerous Condition
Interventions: Selenium; Drug
Lead sponsor: University of Arizona; Other
Eligibility: 40 Years to 80 Years
Enrollment: 1,621 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2018
U.S. locations: 7
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Tucson, Arizona + 3 more

Conditions: Familial Adenomatous Polyposis
Interventions: Exercise Therapy; Procedure
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Cleveland, Ohio

Conditions: Colon Cancer, Diverticulitis, Colorectal Polyps, Crohn's Disease, Ulcerative Colitis, Rectal Cancer
Interventions: Not listed
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 14 Years to 95 Years
Enrollment: 200,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2017
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Adenomatous Polyp, Crohn Disease, Familial Adenomatous Polyposis, Hereditary Intestinal Polyposis Syndrome, Recurrent Colon Cancer, Stage I Colon Cancer, Stage IIA Colon Cancer, Stage IIB Colon Cancer, Stage IIC Colon Cancer, Stage IIIA Colon Cancer, Stage IIIB Colon Cancer, Stage IIIC Colon Cancer
Interventions: therapeutic laparoscopic surgery; Procedure
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Colon Cancer
Interventions: Tandem Colonoscopy; Device
Lead sponsor: EndoAid; Industry
Eligibility: 40 Years to 75 Years
Enrollment: 126 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Colorectal Neoplasms, Colorectal Cancer
Interventions: Not listed
Lead sponsor: Metabiomics Corp; Industry
Eligibility: 45 Years to 80 Years
Enrollment: 260 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Chevy Chase, Maryland

Conditions: Adenomatous Polyp, Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage I Colon Cancer, Stage I Rectal Cancer, Stage IIA Colon Cancer, Stage IIA Rectal Cancer, Stage IIB Colon Cancer, Stage IIB Rectal Cancer, Stage IIC Colon Cancer, Stage IIC Rectal Cancer, Stage IIIA Colon Cancer, Stage IIIA Rectal Cancer, Stage IIIB Colon Cancer, Stage IIIB Rectal Cancer, Stage IIIC Colon Cancer, Stage IIIC Rectal Cancer
Interventions: erlotinib hydrochloride, placebo, laboratory biomarker analysis; Drug · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 3
States / cities: Long Beach, California • Orange, California • Chicago, Illinois

Search by objective public record fields.

Closure of Mucosal and Submucosal Defects in the Gastrointestinal Tract Using the Novel X-Tack Endoscopic Suturing Device

Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)

Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease

Improving Outpatient Colonoscopy Bowel Prep With the Orton Score

AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test

Ileal Pouch-Anal Anastomosis Registry

Confocal Endomicroscopy for GI Neoplasia Study

Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps

Investigation of β-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous Polyposis

Study of KCC Peptide Application in the Colon

Confocal Probe-based Endoscopic Imaging, Colorectal Cancer, Gastrointestinal (GI) Pathologies

CRC Detection Reliable Assessment With Blood

Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis

A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients

Curcumin in Treating Patients With Familial Adenomatous Polyposis

CB-17-08 Augmented Endoscopy System for Mucosal Lesion Detection During Colonoscopy for Colon Rectal Cancer.

EndoRings Colonoscopy vs Standard Colonoscopy

Selenium for Prevention of Adenomatous Colorectal Polyps

Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)

General Surgical Outcomes Quality Improvement Database (UH-SOCRATES)

Single Incision Laparoscopic Surgery in Treating Patients With Colorectal Disease

Polyp Detection With the EndoRings™: A Randomized Tandem Colonoscopy Study

Microbiome Test for the Detection of Colorectal Polyps and Cancer

Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma